Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

PET imaging in patients with brain metastasis-report of the RANO/PET group

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Galldiks, N, Langen, K-J, Albert, NL, Chamberlain, M, Soffietti, R, Kim, MM, Law, I, Le Rhun, E, Chang, S, Schwarting, J, Combs, SE, Preusser, M, Forsyth, P, Pope, W, Weller, M & Tonn, JC 2019, 'PET imaging in patients with brain metastasis-report of the RANO/PET group', Neuro-Oncology, bind 21, nr. 5, s. 585-595. https://doi.org/10.1093/neuonc/noz003

APA

Galldiks, N., Langen, K-J., Albert, N. L., Chamberlain, M., Soffietti, R., Kim, M. M., Law, I., Le Rhun, E., Chang, S., Schwarting, J., Combs, S. E., Preusser, M., Forsyth, P., Pope, W., Weller, M., & Tonn, J. C. (2019). PET imaging in patients with brain metastasis-report of the RANO/PET group. Neuro-Oncology, 21(5), 585-595. https://doi.org/10.1093/neuonc/noz003

CBE

Galldiks N, Langen K-J, Albert NL, Chamberlain M, Soffietti R, Kim MM, Law I, Le Rhun E, Chang S, Schwarting J, Combs SE, Preusser M, Forsyth P, Pope W, Weller M, Tonn JC. 2019. PET imaging in patients with brain metastasis-report of the RANO/PET group. Neuro-Oncology. 21(5):585-595. https://doi.org/10.1093/neuonc/noz003

MLA

Vancouver

Galldiks N, Langen K-J, Albert NL, Chamberlain M, Soffietti R, Kim MM o.a. PET imaging in patients with brain metastasis-report of the RANO/PET group. Neuro-Oncology. 2019 maj 6;21(5):585-595. https://doi.org/10.1093/neuonc/noz003

Author

Galldiks, Norbert ; Langen, Karl-Josef ; Albert, Nathalie L ; Chamberlain, Marc ; Soffietti, Riccardo ; Kim, Michelle M ; Law, Ian ; Le Rhun, Emilie ; Chang, Susan ; Schwarting, Julian ; Combs, Stephanie E ; Preusser, Matthias ; Forsyth, Peter ; Pope, Whitney ; Weller, Michael ; Tonn, Jörg C. / PET imaging in patients with brain metastasis-report of the RANO/PET group. I: Neuro-Oncology. 2019 ; Bind 21, Nr. 5. s. 585-595.

Bibtex

@article{fdd36809e6a14f53a01a05b4f40aa580,
title = "PET imaging in patients with brain metastasis-report of the RANO/PET group",
abstract = "Brain metastases (BM) from extracranial cancer are associated with significant morbidity and mortality. Effective local treatment options are stereotactic radiotherapy, including radiosurgery or fractionated external beam radiotherapy, and surgical resection. The use of systemic treatment for intracranial disease control also is improving. BM diagnosis, treatment planning, and follow-up is most often based on contrast-enhanced magnetic resonance imaging (MRI). However, anatomic imaging modalities including standard MRI have limitations in accurately characterizing posttherapeutic reactive changes and treatment response. Molecular imaging techniques such as positron emission tomography (PET) characterize specific metabolic and cellular features of metastases, potentially providing clinically relevant information supplementing anatomic MRI. Here, the Response Assessment in Neuro-Oncology working group provides recommendations for the use of PET imaging in the clinical management of patients with BM based on evidence from studies validated by histology and/or clinical outcome.",
author = "Norbert Galldiks and Karl-Josef Langen and Albert, {Nathalie L} and Marc Chamberlain and Riccardo Soffietti and Kim, {Michelle M} and Ian Law and {Le Rhun}, Emilie and Susan Chang and Julian Schwarting and Combs, {Stephanie E} and Matthias Preusser and Peter Forsyth and Whitney Pope and Michael Weller and Tonn, {J{\"o}rg C}",
note = "{\textcopyright} The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.",
year = "2019",
month = may,
day = "6",
doi = "10.1093/neuonc/noz003",
language = "English",
volume = "21",
pages = "585--595",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "5",

}

RIS

TY - JOUR

T1 - PET imaging in patients with brain metastasis-report of the RANO/PET group

AU - Galldiks, Norbert

AU - Langen, Karl-Josef

AU - Albert, Nathalie L

AU - Chamberlain, Marc

AU - Soffietti, Riccardo

AU - Kim, Michelle M

AU - Law, Ian

AU - Le Rhun, Emilie

AU - Chang, Susan

AU - Schwarting, Julian

AU - Combs, Stephanie E

AU - Preusser, Matthias

AU - Forsyth, Peter

AU - Pope, Whitney

AU - Weller, Michael

AU - Tonn, Jörg C

N1 - © The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

PY - 2019/5/6

Y1 - 2019/5/6

N2 - Brain metastases (BM) from extracranial cancer are associated with significant morbidity and mortality. Effective local treatment options are stereotactic radiotherapy, including radiosurgery or fractionated external beam radiotherapy, and surgical resection. The use of systemic treatment for intracranial disease control also is improving. BM diagnosis, treatment planning, and follow-up is most often based on contrast-enhanced magnetic resonance imaging (MRI). However, anatomic imaging modalities including standard MRI have limitations in accurately characterizing posttherapeutic reactive changes and treatment response. Molecular imaging techniques such as positron emission tomography (PET) characterize specific metabolic and cellular features of metastases, potentially providing clinically relevant information supplementing anatomic MRI. Here, the Response Assessment in Neuro-Oncology working group provides recommendations for the use of PET imaging in the clinical management of patients with BM based on evidence from studies validated by histology and/or clinical outcome.

AB - Brain metastases (BM) from extracranial cancer are associated with significant morbidity and mortality. Effective local treatment options are stereotactic radiotherapy, including radiosurgery or fractionated external beam radiotherapy, and surgical resection. The use of systemic treatment for intracranial disease control also is improving. BM diagnosis, treatment planning, and follow-up is most often based on contrast-enhanced magnetic resonance imaging (MRI). However, anatomic imaging modalities including standard MRI have limitations in accurately characterizing posttherapeutic reactive changes and treatment response. Molecular imaging techniques such as positron emission tomography (PET) characterize specific metabolic and cellular features of metastases, potentially providing clinically relevant information supplementing anatomic MRI. Here, the Response Assessment in Neuro-Oncology working group provides recommendations for the use of PET imaging in the clinical management of patients with BM based on evidence from studies validated by histology and/or clinical outcome.

U2 - 10.1093/neuonc/noz003

DO - 10.1093/neuonc/noz003

M3 - Journal article

C2 - 30615138

VL - 21

SP - 585

EP - 595

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 5

ER -

ID: 59320346